MYRIAD GENETICS, INC. (MYGN) Share buybacks
- Total buybacks · last 12 months (USD): Value $0.00; Formula and calculation Trailing-year cash paid for share repurchases. Period ending 2021-12-31..
- Buyback yield · 12 months: Value (m); Formula and calculation Cash paid for share repurchases / current market cap. Period ending 2021-12-31..
Share buybacks
Overview →Financial period ending 2021-12-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total buybacks · last 12 months (USD) | $0.00 | Trailing-year cash paid for share repurchases. Period ending 2021-12-31. |
| Buyback yield · 12 months | (m) | Cash paid for share repurchases / current market cap. Period ending 2021-12-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Buybacks · 12 months | 0.00 USD | Payments for Repurchase of Common Stock |
| Market cap | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total buybacks | Market cap (USD) | Buyback yield |
|---|---|---|---|
| 2021-12-31 | $0.00 | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) |
| 2020-06-30 | $0.00 | (m) | (m) |
| 2019-06-30 | $50.00M | (m) | (m) |
| 2019-03-31 | (m) | (m) | (m) |
| 2018-12-31 | (m) | (m) | (m) |
| 2018-06-30 | $0.00 | (m) | (m) |
| 2017-06-30 | $31.60M | (m) | (m) |
| 2017-03-31 | $86.30M | (m) | (m) |
| 2016-12-31 | $131.30M | (m) | (m) |
| 2016-09-30 | $145.90M | (m) | (m) |
| 2016-06-30 | $162.60M | (m) | (m) |
| 2016-03-31 | $152.70M | (m) | (m) |
| 2015-12-31 | $169.70M | (m) | (m) |
| 2015-09-30 | $203.10M | (m) | (m) |
| 2015-06-30 | $210.70M | (m) | (m) |
| 2015-03-31 | $231.63M | (m) | (m) |
| 2014-12-31 | $211.53M | (m) | (m) |
| 2014-09-30 | $231.02M | (m) | (m) |
| 2014-06-30 | $287.70M | (m) | (m) |
| 2014-03-31 | $243.58M | (m) | (m) |
| 2013-12-31 | $246.51M | (m) | (m) |
| 2013-09-30 | $202.38M | (m) | (m) |
| 2013-06-30 | $146.27M | (m) | (m) |
| 2013-03-31 | $185.70M | (m) | (m) |
| 2012-12-31 | $152.88M | (m) | (m) |
| 2012-09-30 | $137.49M | (m) | (m) |
| 2012-06-30 | $128.47M | (m) | (m) |
| 2012-03-31 | $89.35M | (m) | (m) |
| 2011-12-31 | $165.42M | (m) | (m) |
| 2011-09-30 | $209.06M | (m) | (m) |
| 2011-06-30 | $200.49M | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) |
| 2011-03-01 | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) |
| 2010-08-31 | (m) | (m) | (m) |
| 2010-06-30 | $71.39M | (m) | (m) |
| 2010-05-04 | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |